Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apoptosis Regulatory Proteins”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Testing effectiveness (Phase 2)Study completedNCT02968940
What this trial is testing

Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma

Who this might be right for
Glioblastoma
NYU Langone Health 6
Not applicableStudy completedNCT06865976
What this trial is testing

Genomic and Proteomic Analyses of Apoptosis Mechanisms in Diseased Peri-implant Tissue

Who this might be right for
ApoptosisApoptosis Regulatory ProteinsProteases+1 more
Sakarya University 72
Large-scale testing (Phase 3)UnknownNCT04084626
What this trial is testing

PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBV

Who this might be right for
EBV Infection
Beijing Friendship Hospital 40
Not applicableUnknownNCT04922541
What this trial is testing

Multi-center Observational Study on the Progression of Atherosclerotic Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up

Who this might be right for
Plaque, AtheroscleroticProgrammed Cell Death Protein 1 Inhibitor
Second Affiliated Hospital, Zhejiang University, School of Medicine 50
Early research (Phase 1)WithdrawnNCT03920839
What this trial is testing

INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)

Who this might be right for
Advanced and/or Metastatic Solid TumorsStage IIIB Not Amenable to Curative Therapy to Stage IV Non-small Cell Lung CancerAdvanced/Metastatic Unresectable Malignant Pleural Mesothelioma
Incyte Corporation
Early research (Phase 1)Study completedNCT03003676
What this trial is testing

A Pilot Study of Sequential ONCOS-102, an Engineered Oncolytic Adenovirus Expressing GMCSF, and Pembrolizumab in Patients With Advanced or Unresectable Melanoma Progressing After Programmed Cell Death Protein 1 (PD1) Blockade

Who this might be right for
Advanced or Unresectable Melanoma Progressing After PD1 Blockade
Targovax Oy 21
Large-scale testing (Phase 3)WithdrawnNCT03342352
What this trial is testing

Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)

Who this might be right for
Head and Neck Cancer
Incyte Corporation
Testing effectiveness (Phase 2)UnknownNCT04885413
What this trial is testing

An Open-label, Single Arm, Phase II Trial of Niraparib in Combination With Anti-PD1（Programmed Cell Death Protein 1） Antibody in Recurrent/ Advanced Stage Endometrial Cancer Patients

Who this might be right for
Recurrent/ Advanced Stage Endometrial Cancer Patients
Sun Yat-sen University 37
Early research (Phase 1)Ended earlyNCT04458259
What this trial is testing

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Who this might be right for
Neoplasm Metastasis
Pfizer 88
Early research (Phase 1)Looking for participantsNCT05142189
What this trial is testing

Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
BioNTech SE 320
Testing effectiveness (Phase 2)Looking for participantsNCT06413680
What this trial is testing

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Who this might be right for
MelanomaClear-Cell Renal-Cell Carcinoma (ccRCC)Advanced Solid Tumors
Regeneron Pharmaceuticals 240
Testing effectiveness (Phase 2)WithdrawnNCT03197571
What this trial is testing

QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy

Who this might be right for
Urothelial Carcinoma
ImmunityBio, Inc.
Not applicableStudy completedNCT05432622
What this trial is testing

Treatment Patterns and Outcomes in Participants With Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy

Who this might be right for
Melanoma
Bristol-Myers Squibb 95
Testing effectiveness (Phase 2)UnknownNCT04586465
What this trial is testing

Dynamic PET/CT Evaluated the Response of Neoadjuvant Anti-PD1 Combination With Chemotherapy for Ⅱa-Ⅲb NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IINon-small Cell Lung Cancer Stage IIIPET/CT
Fifth Affiliated Hospital, Sun Yat-Sen University 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT05975307
What this trial is testing

Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation

Who this might be right for
Muscle-Invasive Bladder CarcinomaProgrammed Cell Death Protein 1 InhibitorRadiotherapy
Sun Yat-sen University 71
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07740941
What this trial is testing

NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma

Who this might be right for
Melanoma (Skin Cancer)Melanoma Stage Stage IIIBMelanoma Stage M1+1 more
UNC Lineberger Comprehensive Cancer Center 55
Testing effectiveness (Phase 2)Study completedNCT04361331
What this trial is testing

Two-cohort Study of Toripalimab(PD1)+Lenvatnib, or Gemox+Lenvatinib in Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Shanghai Zhongshan Hospital 61
Testing effectiveness (Phase 2)Ended earlyNCT04319224
What this trial is testing

Vopratelimab (JTX-2011) Alone and in Combination With Anti-Programmed Cell Death Protein 1 (PD-1) or Anti-Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) in Subjects With Advanced and/or Refractory Solid Tumors

Who this might be right for
Cancer
Jounce Therapeutics, Inc. 4
Testing effectiveness (Phase 2)Study completedNCT03317327
What this trial is testing

REirradiation and Programmed Cell Death Protein 1 (PD-1) Blockade On Recurrent Squamous Cell Head and Neck Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Oslo University Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04483219
What this trial is testing

Tyrosine Kinase Inhibitor (TKI) + Anti-PD-1 Antibody in TKI-responded Microsatellite Stability/Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Adenocarcinoma.

Who this might be right for
MSSpMMRMetastatic Colorectal Adenocarcinoma
China Medical University, China 53
Next Page